A citation-based method for searching scientific literature

Ona Kinduryte Schorling, Douglas Clark, Isabella Zwiener, Stefan Kaspers, Jisoo Lee, Hristo Iliev. Adv Ther 2020
Times Cited: 3







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials.
Huilin Tang, Qi Dai, Weilong Shi, Suodi Zhai, Yiqing Song, Jiali Han. Diabetologia 2017
48
66


Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
Nir Barzilai, Hua Guo, Erin M Mahoney, Suzanne Caporossi, Gregory T Golm, Ronald B Langdon, Debora Williams-Herman, Keith D Kaufman, John M Amatruda, Barry J Goldstein,[...]. Curr Med Res Opin 2011
100
33

Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study.
Peter Ueda, Henrik Svanström, Mads Melbye, Björn Eliasson, Ann-Marie Svensson, Stefan Franzén, Soffia Gudbjörnsdottir, Kristian Hveem, Christian Jonasson, Björn Pasternak. BMJ 2018
121
33

Efficacy and safety of linagliptin to improve glucose control in older people with type 2 diabetes on stable insulin therapy: A randomized trial.
Gilbert Ledesma, Guillermo E Umpierrez, John E Morley, Diane Lewis-D'Agostino, Annett Keller, Thomas Meinicke, Sandra van der Walt, Maximilian von Eynatten. Diabetes Obes Metab 2019
9
33


Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study.
Frederick A Masoudi, Silvio E Inzucchi, Yongfei Wang, Edward P Havranek, JoAnne M Foody, Harlan M Krumholz. Circulation 2005
343
33

Thiazolidinedione use in elderly patients with type 2 diabetes: with and without heart failure.
Jong-Mi Seong, Nam-Kyong Choi, Sun-Young Jung, Yoosoo Chang, Ye-Jee Kim, Joongyub Lee, Byung-Joo Park. Pharmacoepidemiol Drug Saf 2011
5
33

Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer.
A S Abdelmoneim, D T Eurich, P E Light, P A Senior, J M Seubert, M J Makowsky, S H Simpson. Diabetes Obes Metab 2015
45
33


Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infection: A population-based study of older women and men with diabetes.
Iliana C Lega, Susan E Bronskill, Michael A Campitelli, Jun Guan, Nathan M Stall, Kenneth Lam, Lisa M McCarthy, Andrea Gruneir, Paula A Rochon. Diabetes Obes Metab 2019
31
33

Association between dipeptidyl peptidase-4 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: A population-based cohort study.
Chen-Yi Wu, Chun-Ying Wu, Chung-Pin Li, Yiing-Jenq Chou, Yi-Hsian Lin, Yun-Ting Chang. Diabetes Res Clin Pract 2021
1
100

Sodium-glucose co-transporter-2 inhibitor use and risk of lower-extremity amputation: Evolving questions, evolving answers.
Jeff Y Yang, Tiansheng Wang, Virginia Pate, Emily W Gower, Matthew J Crowley, John B Buse, Til Stürmer. Diabetes Obes Metab 2019
17
33


Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study.
Francesco Zaccardi, Suping Ling, Claire Lawson, Melanie J Davies, Kamlesh Khunti. Diabetologia 2020
4
33



Is avoidance of hypoglycaemia a better target than HbA1C in older people with diabetes?
Katharina Mattishent, Yoon Kong Loke. Br J Clin Pharmacol 2021
3
33

Management of type 2 diabetes in treatment-naive elderly patients: benefits and risks of vildagliptin monotherapy.
Richard E Pratley, Julio Rosenstock, F Xavier Pi-Sunyer, Mary Ann Banerji, Anja Schweizer, Andre Couturier, Sylvie Dejager. Diabetes Care 2007
88
33


Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus.
Qian Shi, Shuqian Liu, Vivian A Fonseca, Tina K Thethi, Lizheng Shi. BMJ Open 2019
19
33

Efficacy of SGLT-2 inhibitors in older adults with diabetes: Systematic review with meta-analysis of cardiovascular outcome trials.
Dario Giugliano, Miriam Longo, Maria Ida Maiorino, Giuseppe Bellastella, Paolo Chiodini, Sebastiano Bruno Solerte, Katherine Esposito. Diabetes Res Clin Pract 2020
9
33

A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin.
Azim S Gangji, Tali Cukierman, Hertzel C Gerstein, Charles H Goldsmith, Catherine M Clase. Diabetes Care 2007
184
33

Does lower limb amputation concern all SGLT2 inhibitors?
André J Scheen. Nat Rev Endocrinol 2018
20
33

A cohort study of thiazolidinediones and fractures in older adults with diabetes.
Daniel H Solomon, Suzanne M Cadarette, Niteesh K Choudhry, Claire Canning, Raisa Levin, Til Stürmer. J Clin Endocrinol Metab 2009
61
33


Nateglinide, alone or in combination with metformin, is effective and well tolerated in treatment-naïve elderly patients with type 2 diabetes.
S L Schwarz, J E Gerich, A Marcellari, L Jean-Louis, D Purkayastha, M A Baron. Diabetes Obes Metab 2008
20
33


Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus.
Rachel A Whitmer, Andrew J Karter, Kristine Yaffe, Charles P Quesenberry, Joseph V Selby. JAMA 2009
582
33

Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes.
Alan Sinclair, John E Morley, Leo Rodriguez-Mañas, Giuseppe Paolisso, Tony Bayer, Andrej Zeyfang, Isabelle Bourdel-Marchasson, Ulrich Vischer, Jean Woo, Ian Chapman,[...]. J Am Med Dir Assoc 2012
251
33


Study design choices for evaluating the comparative safety of diabetes medications: An evaluation of pioglitazone use and risk of bladder cancer in older US adults with type-2 diabetes.
Elizabeth M Garry, John B Buse, Mugdha Gokhale, Jennifer L Lund, Matthew E Nielsen, Virginia Pate, Til Stürmer. Diabetes Obes Metab 2019
4
33

Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study.
Judith van Dalem, Martijn C G J Brouwers, Coen D A Stehouwer, André Krings, Hubert G M Leufkens, Johanna H M Driessen, Frank de Vries, Andrea M Burden. BMJ 2016
36
33

Benefits of Metformin in Attenuating the Hallmarks of Aging.
Ameya S Kulkarni, Sriram Gubbi, Nir Barzilai. Cell Metab 2020
59
33

Effectiveness and safety of dipeptidyl peptidase 4 inhibitors in the management of type 2 diabetes in older adults: a systematic review and development of recommendations to reduce inappropriate prescribing.
Gisela Schott, Yolanda V Martinez, R Erandie Ediriweera de Silva, Anna Renom-Guiteras, Anna Vögele, David Reeves, Ilkka Kunnamo, Minna Marttila-Vaara, Andreas Sönnichsen. BMC Geriatr 2017
15
33

SGLT2 Inhibitors and Bladder Cancer: Analysis of Cases Reported in the European Pharmacovigilance Database.
Montserrat García, Unai Arteche-Martinez, Unax Lertxundi, Carmelo Aguirre. J Clin Pharmacol 2021
2
50


A systematic review of observational studies of the association between pioglitazone use and bladder cancer.
E Ripamonti, L Azoulay, M Abrahamowicz, R W Platt, S Suissa. Diabet Med 2019
13
33


Safety of type 2 diabetes treatment with repaglinide compared with glibenclamide in elderly people: A randomized, open-label, two-period, cross-over trial.
Giuseppe Papa, Viviana Fedele, Maria Rosaria Rizzo, Marisa Fioravanti, Carmelo Leotta, Sebastiano Bruno Solerte, Francesco Purrello, Giuseppe Paolisso. Diabetes Care 2006
49
33


Efficacy and safety of metformin in the management of type 2 diabetes mellitus in older adults: a systematic review for the development of recommendations to reduce potentially inappropriate prescribing.
Lisa Schlender, Yolanda V Martinez, Charles Adeniji, David Reeves, Barbara Faller, Christina Sommerauer, Thekraiat Al Qur'an, Adrine Woodham, Ilkka Kunnamo, Andreas Sönnichsen,[...]. BMC Geriatr 2017
22
33

Current Progress on Peroxisome Proliferator-activated Receptor Gamma Agonist as an Emerging Therapeutic Approach for the Treatment of Alzheimer's Disease: An Update.
Mahmood Ahmad Khan, Qamre Alam, Absarul Haque, Mohammad Ashafaq, Mohd Jahir Khan, Ghulam Md Ashraf, Mahboob Ahmad. Curr Neuropharmacol 2019
19
33

Metformin-associated lactic acidosis (MALA): Moving towards a new paradigm.
Jean-Daniel Lalau, Farshad Kajbaf, Alessandro Protti, Mette M Christensen, Marc E De Broe, Nicolas Wiernsperger. Diabetes Obes Metab 2017
53
33

Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.
Derek LeRoith, Geert Jan Biessels, Susan S Braithwaite, Felipe F Casanueva, Boris Draznin, Jeffrey B Halter, Irl B Hirsch, Marie E McDonnell, Mark E Molitch, M Hassan Murad,[...]. J Clin Endocrinol Metab 2019
85
33

Pancreatitis and pancreatic cancer in patientes treated with Dipeptidyl Peptidase-4 inhibitors: An extensive and updated meta-analysis of randomized controlled trials.
Ilaria Dicembrini, Chiara Montereggi, Besmir Nreu, Edoardo Mannucci, Matteo Monami. Diabetes Res Clin Pract 2020
6
33

Use of metformin in the setting of mild-to-moderate renal insufficiency.
Kasia J Lipska, Clifford J Bailey, Silvio E Inzucchi. Diabetes Care 2011
258
33

Safety and efficacy of rosiglitazone in the elderly diabetic patient.
Adie Viljoen, Alan Sinclair. Vasc Health Risk Manag 2009
7
33

Use of SGLT2 Inhibitors in Older Adults: Scientific Evidence and Practical Aspects.
Joaquim Silva Custódio, Jarbas Roriz-Filho, Catarina Addobbati Jordão Cavalcanti, Amanda Martins, João Eduardo Nunes Salles. Drugs Aging 2020
1
100

Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial.
Julio Rosenstock, Vlado Perkovic, Odd Erik Johansen, Mark E Cooper, Steven E Kahn, Nikolaus Marx, John H Alexander, Michael Pencina, Robert D Toto, Christoph Wanner,[...]. JAMA 2019
384
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.